Literature DB >> 2408797

Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children.

M Bondestam, K Funa, P Venge, G V Alm.   

Abstract

The ability of neutrophil granulocytes (PMN) from 15 infection prone children to produce luminol enhanced chemiluminescence (CL) was disturbed to varying extents in eight patients, two of whom were diagnosed as having chronic granulomatous disease (CGD). The ability of peripheral blood mononuclear leucocytes (PBL) to produce interferons (IFN) was normal, as tested with the inducers Sendai virus, E. coli, concanavalin A and L. culinaris lectin. However, the IFN response to the inducer S. aureus Cowan I (SACoI) was decreased in patients with normal CL and tended to be increased in those with decreased CL. There was a significant inverse relation between the CL of PMN and the SACoI-induced IFN responses by PBL of the patients. A regulatory effect of products of oxidative metabolism on SACoI-induced IFN production is therefore suggested. Patients, including those with CGD and controls showed similar basal and in vitro IFN enhanced natural killer (NK) activity of PBL against K-562 erythroleukaemia cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408797      PMCID: PMC1577007     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Mechanism of the luminol-dependent chemiluminescence of human neutrophils.

Authors:  L R DeChatelet; G D Long; P S Shirley; D A Bass; M J Thomas; F W Henderson; M S Cohen
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

2.  Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors.

Authors:  L Håkansson; P Venge
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

3.  The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.

Authors:  J Werkmeister; S Helfand; J Roder; H Pross
Journal:  Eur J Immunol       Date:  1983-06       Impact factor: 5.532

4.  Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance.

Authors:  A W Segal; A R Cross; R C Garcia; N Borregaard; N H Valerius; J F Soothill; O T Jones
Journal:  N Engl J Med       Date:  1983-02-03       Impact factor: 91.245

6.  Neutrophil function in infection-prone children.

Authors:  L Håkansson; T Foucard; R Hällgren; P Venge
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

7.  Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood.

Authors:  L Rönnblom; A Forsgren; G V Alm
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas.

Authors:  K Funa; B Nilsson; G Jacobsson; G V Alm
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

9.  Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.

Authors:  S L Helfand; J Werkmeister; J C Roder
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.

Authors:  Natsuko Onishi; Masako Kataoka
Journal:  Breast Cancer       Date:  2020-09-21       Impact factor: 4.239

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.